Compare Stocks

→ SHOCKING Crypto Leak… (From Crypto 101 Media) (Ad)

Compare stocks and their fundamentals, performance, price, and technicals. Use this free stock comparison tool to evaluate companies based on their analyst ratings, book value, debt, dividend, MarketRank, news sentiment, price performance, profitability, and more. Enter up to ten stock symbols separated by a comma or space (ex. BAC, JPM, WFC, C, GS).

Comparative Price Performance Over Time

Compare Stocks - Price & Volume

Company	Current Price	50-Day Moving Average	52-Week Range	Market Cap	Beta	Avg. Volume	Today's Volume
BGXX Bright Green	$0.20	$0.24	$0.15 ▼ $1.81	$37.60M	0.72	1.72 million shs	342,156 shs
MNMD Mind Medicine (MindMed)	$8.87 +2.2%	$8.23	$2.41 ▼ $12.22	$623.30M	2.8	1.93 million shs	1.20 million shs
VLNS Valens	$0.76	$0.73	$0.58 ▼ $3.00	$61.38M	N/A	221,089 shs	N/A

10 "Recession Proof" Stocks That Will Thrive in Any Market

Which stocks are likely to thrive in today's challenging market? Click the link below and we'll send you MarketBeat's list of ten stocks that will drive in any economic environment.

Get This Free Report

Price Performance

Company	1-Day Performance	7-Day Performance	30-Day Performance	90-Day Performance	1-Year Performance
BGXX Bright Green	-6.69%	-12.15%	-26.08%	-15.74%	-85.64%
MNMD Mind Medicine (MindMed)	0.00%	-11.25%	-11.25%	+130.85%	+119.75%
VLNS Valens	0.00%	0.00%	0.00%	0.00%	0.00%

SHOCKING Crypto Leak… (Ad)

A shocking leak has revealed tech giant Microsoft's plans to add crypto support to future products. If the plans in these leaked internal documents pan out, we could see prices skyrocket for Bitcoin, Ethereum, XRP and MORE… The coupling of gaming and cryptocurrency could absolutely transform digital finance as we know it in 2024.

Claim your free seat by clicking here now.

MarketRank™

Company	Overall Score	Analyst's Opinion	Short Interest Score	Dividend Strength	ESG Score	News and Social Media Sentiment	Company Ownership	Earnings & Valuation
BGXX Bright Green	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
MNMD Mind Medicine (MindMed)	1.694 of 5 stars	3.5	2.0	0.0	0.0	2.5	0.8	0.6
VLNS Valens	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A

Analyst Ratings

Company	Consensus Rating Score	Consensus Rating	Consensus Price Target	% Upside from Current Price
BGXX Bright Green	N/A	N/A	N/A	N/A
MNMD Mind Medicine (MindMed)	3.00	Buy	$25.20	184.10% Upside
VLNS Valens	N/A	N/A	N/A	N/A

Current Analyst Ratings

Latest MNMD, BGXX, and VLNS Analyst Ratings

Date	Company	Brokerage	Action	Rating	Price Target
4/15/2024	MNMD Mind Medicine (MindMed)	Leerink Partnrs Subscribe to MarketBeat All Access for the recommendation accuracy rating	Reiterated Rating	Outperform
4/15/2024	MNMD Mind Medicine (MindMed)	SVB Leerink Subscribe to MarketBeat All Access for the recommendation accuracy rating	Initiated Coverage	Outperform	$20.00
3/14/2024	MNMD Mind Medicine (MindMed)	HC Wainwright Subscribe to MarketBeat All Access for the recommendation accuracy rating	Reiterated Rating	Buy ➝ Buy	$75.00
3/1/2024	MNMD Mind Medicine (MindMed)	HC Wainwright Subscribe to MarketBeat All Access for the recommendation accuracy rating	Reiterated Rating	Buy ➝ Buy	$75.00
2/29/2024	MNMD Mind Medicine (MindMed)	Royal Bank of Canada Subscribe to MarketBeat All Access for the recommendation accuracy rating	Boost Price Target	Outperform ➝ Outperform	$14.00 ➝ $15.00

(Data available from 4/23/2021 forward. View 10+ years of historical ratings with our analyst ratings screener.)

Sales & Book Value

Company	Annual Revenue	Price/Sales	Cashflow	Price/Cash	Book Value	Price/Book
BGXX Bright Green	N/A	N/A	N/A	N/A	$0.06 per share	N/A
MNMD Mind Medicine (MindMed)	N/A	N/A	N/A	N/A	$1.90 per share	N/A
VLNS Valens	$62.37M	0.98	N/A	N/A	$1.30 per share	0.58

Profitability & Earnings

Company	Net Income	EPS	Trailing P/E Ratio	Forward P/E Ratio	P/E Growth	Net Margins	Return on Equity (ROE)	Return on Assets (ROA)	Next Earnings Date
BGXX Bright Green	-$13.13M	-$0.08	N/A	∞	N/A	N/A	-101.64%	-57.83%	5/27/2024 (Estimated)
MNMD Mind Medicine (MindMed)	-$95.73M	-$2.45	N/A	N/A	N/A	N/A	-89.72%	-65.33%	5/2/2024 (Estimated)
VLNS Valens	-$39.11M	-$2.51	N/A	N/A	N/A	-274.38%	-48.02%	-29.74%	N/A

Latest MNMD, BGXX, and VLNS Earnings

Date	Quarter	Company	Consensus Estimate	Reported EPS	Beat/Miss	Gap EPS	Revenue Estimate	Actual Revenue	Details
2/28/2024	Q4 2023	MNMD Mind Medicine (MindMed)	-$0.48	-$0.59	-$0.11	-$0.59	N/A	N/A

Dividends

Company	Annual Payout	Dividend Yield	3-Year Dividend Growth	Payout Ratio	Years of Consecutive Growth
BGXX Bright Green	N/A	N/A	N/A	N/A	N/A
MNMD Mind Medicine (MindMed)	N/A	N/A	N/A	N/A	N/A
VLNS Valens	N/A	N/A	N/A	N/A	N/A

Debt

Company	Debt-to-Equity Ratio	Current Ratio	Quick Ratio
BGXX Bright Green	0.02	0.04	0.04
MNMD Mind Medicine (MindMed)	0.18	3.22	3.22
VLNS Valens	0.80	2.08	1.49

Ownership

Institutional Ownership

Company	Institutional Ownership
BGXX Bright Green	7.83%
MNMD Mind Medicine (MindMed)	27.91%
VLNS Valens	3.57%

Insider Ownership

Company	Insider Ownership
BGXX Bright Green	51.38%
MNMD Mind Medicine (MindMed)	2.11%
VLNS Valens	3.77%

Miscellaneous

Company	Employees	Shares Outstanding	Free Float	Optionable
BGXX Bright Green	23	190.17 million	92.46 million	Optionable
MNMD Mind Medicine (MindMed)	57	70.27 million	68.79 million	Optionable
VLNS Valens	445	80.74 million	77.70 million	Not Optionable

MNMD, BGXX, and VLNS Headlines

Source	Headline
	SNDL targets $30M in synergies from 1Q Valens acquisition by the end of 2024 proactiveinvestors.com - May 15 at 1:45 PM
	John Tichy and friends to present their anniversary tribute to Buddy Holly, Ritchie Valens and the Big Bopper dailygazette.com - April 19 at 9:09 AM
	Closing Bell: The Valens Company Inc. down on Wednesday (VLNS) theglobeandmail.com - April 2 at 8:33 PM
	Valens Semiconductor Stock (NYSE:VLN), Quotes and News Summary benzinga.com - March 4 at 4:58 PM
	Consolidation Continues To Be A Key Trend In The Cannabis Sector technical420.com - January 19 at 2:31 PM
	SNDL Closes Valens Acquisition newcannabisventures.com - January 17 at 1:30 PM
	The Valens Company acquisition wrapped up by Canada's largest private liquor and cannabis retailer SNDL proactiveinvestors.com - January 17 at 1:30 PM
	Cannabis Giant SNDL Grows Bigger: Finalizes Valens Acquisition Becoming 'A Leader And Trusted Partner' In Canadian Marijuana Space msn.com - January 17 at 1:30 PM
	Valens Obtains Final Court Order Approving Merger With SNDL benzinga.com - January 4 at 8:55 AM
	Why SNDL Stock Flew as High as 5% on Tuesday msn.com - January 3 at 8:25 PM
	Will Valens Remain On Nasdaq? It Has 180 Days to Regain Compliance With Minimum Bid Price Rule On This Stock Exchange markets.businessinsider.com - December 14 at 12:40 PM
	The Valens Company Granted Additional 180 Calendar Day Grace Period by Nasdaq to Regain Compliance with Minimum Bid Price Rule finance.yahoo.com - December 13 at 9:38 PM
	The Valens Company says shareholders overwhelmingly vote in favour of takeover by SNDL proactiveinvestors.com - November 30 at 11:39 AM
	Valens Shareholders Approve The Arrangement With SNDL benzinga.com - November 30 at 11:39 AM
	Valens Shareholders Vote in Favour of the Arrangement with SNDL prnewswire.com - November 29 at 5:12 PM
	BOTH LEADING INDEPENDENT PROXY ADVISORS RECOMMEND SHAREHOLDERS OF THE VALENS COMPANY INC. VOTE FOR THE PROPOSED ARRANGEMENT WITH SNDL INC. finance.yahoo.com - November 22 at 6:46 PM
	Valens Secures License To Sell Micro Processed Cannabis Products From Its Pommies Beverage Facility msn.com - November 3 at 1:54 PM
	The Valens Company receives sales licence amendment from Health Canada for its Pommies manufacturing facility proactiveinvestors.com - November 3 at 8:53 AM
	Valens Secures Sales Licence for Greater Toronto Area Beverage Facility finance.yahoo.com - November 2 at 5:50 PM
	The Valens Announces Mailing And Filing Of Circular For Special Meeting Of Shareholders To Approve Arrangement With SNDL msn.com - October 28 at 1:22 PM
	THE VALENS COMPANY ANNOUNCES MAILING AND FILING OF CIRCULAR FOR SPECIAL MEETING OF SHAREHOLDERS TO APPROVE ARRANGEMENT WITH SNDL INC. finance.yahoo.com - October 27 at 5:20 PM
	Stifel GMP analysts repeat ‘Buy’ rating and C$1.20 price target for The Valens Company on robust 3Q results proactiveinvestors.com - October 15 at 1:51 PM
	The Valens Company reports higher 3Q adjusted gross profit as integration initiatives kick in proactiveinvestors.com - October 13 at 10:52 AM
	Valens Q3 Revenue Declines 15% Sequentially to C$20.3 Million newcannabisventures.com - October 13 at 10:52 AM

New MarketBeat Followers Over Time

Media Sentiment Over Time

Company Descriptions

Bright Green

NASDAQ:BGXX

Bright Green Corporation focuses on the cultivation, manufacture, and sale of cannabis and cannabis-related products. Its products are used in research, pharmaceutical applications, and affiliated exports. The company was incorporated in 2019 and is based in Grants, New Mexico.

Mind Medicine (MindMed)

NASDAQ:MNMD

Mind Medicine (MindMed) Inc., a clinical stage biopharmaceutical company, develops novel products to treat brain health disorders. The company's lead product candidates include MM-120, which is in phase 2 for the treatment of generalized anxiety disorder and attention deficit hyperactivity disorder; and MM-402, a R-enantiomer of 3,4-methylenedioxymethamphetamine for the treatment of core symptoms of autism spectrum disorder. The company also develops MM-110, an a3ß4 nicotinic cholinergic receptor antagonist that has completed phase 1 for the treatment of opioid withdrawal. The company is headquartered in New York, New York.

Valens

NASDAQ:VLNS

The Valens Company Inc., through its subsidiaries, develops, manufactures, and sells cannabinoid-based products in Canada, the United States, and internationally. The company provides packaged dried flower/pre-rolls under the Verse, Versus, Contraband, and Citizen Stash brands; vapourizers and hydrocarbon extracts under the Verse and Versus brands; edible cannabis products under the Verse, Vacay, and LYF brands; and topical cannabis under the Nuance brand. It also offers analytical testing services to third party licensed producers in the cannabis space. The company is headquartered in Toronto, Canada.

Get 30 Days of MarketBeat All Access Free

Best-in-Class Portfolio Monitoring
View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio.
Stock Ideas and Recommendations
Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report.
Advanced Stock Screeners and Research Tools
Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis.

Start Your 30-Day Free Trial